NIH Funding · FY2024
Total Funding
$3M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#2,685
Among 57,894 PIs
First NIH Award
2024
Year of first funding
Funding & rank history
NIH funding totals and national rank by fiscal year.
Single fiscal year on record (FY2024): $3M across 3 grants · National rank #2685.
Top grants by award amount
Upendra Marathi's NIH grant portfolio, ranked by award amount.
- 5R44CA285207-02R447HP349, an Integrin Activator to Treat Patients With anti-PD-1 Resistant Solid Tumors$999.2Kaward amount
- 5R44AI172437-03R44Integrin activator-adjuvanted DNA vaccine against Trypanosoma cruzi infection$997.9Kaward amount
- 5R44AI176894-02R447HP349, an oral integrin activator to augment effectiveness of pre-exposure influenza vaccination$953.5Kaward amount
Affiliation
Institutions that have administered grants for Upendra Marathi.
Affiliated with 7 Hills Pharma, LLC (TX).
Career milestones
Key NIH funding milestones over time.
- 2024First NIH Award7 Hills Pharma, LLC
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #2685
- 2024Entered Top 25% NationallyRanked #2685
Related investigators
Other NIH-funded PIs frequently associated with Upendra Marathi.
Explore further
Find collaborators for Upendra Marathi
Search NIH-funded principal investigators by topic, department, or activity.
Open Find Collaborators →Check S10 eligibility at 7 Hills Pharma, LLC
Review past S10 Shared Instrumentation Grant awards and equipment categories.
Open S10 Eligibility Finder →Benchmark grant budgets
Compare median NIH grant budgets across departments, mechanisms, and years.
Open Grant Budget Benchmark →